logo
Sign in

MAXCYTE, INC.

GAITHERSBURG, MD · Biotech · Public

ExPERT™ instruments for automated cell engineering and processing

Claim this profile

Follows are private to you and power your alerts

Updated · maxcyte.com

Sector
Biotech
Headquarters
GAITHERSBURG, MD
Latest Form D
$760K, Sep 2016
Total capital
$5.5M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$3.6M
3 Form D · last Sep 2016
121 months since last filing
Federal contracts
$1.9M
25 awards · Health and Human S, Veterans Affairs
Rank in Biotech#142 of 4373
Granted patents
28
12 pending · first 2017
Rank in peer group#1 of 32

Capital timeline

20082012201620202024FEDERAL ↑EQUITY ↓Cumulative $5.5M$375K$120K$165K$114K$126K$126K1st Form D$1.1M2nd Form D$1.7M3rd Form D$760K
20082012201620202024FEDERAL ↑EQUITY ↓Cumulative $5.5M$375K$165K$126K$126K3rd Form D$760K

Latest events

  • Federal contractHealth and Human S · 26-008363 Maxcyte Expert Gtx Electroporation Device And Installation/operational Qualification (iq/oq)$126K
  • Federal contractHealth and Human S · 26-003578 Maxcyte Expert Gtx Electroporation Device And Installation/operational Qualification (iq/oq)$126K
  • Federal contractHealth and Human S · Expert Atx Electroporation Platform, Generation 3 With Accessories (region Specific Power Cord)$55K
  • Federal contractVeterans Affairs · Maxcyte Expert Atx Electroporation System$50K
  • Federal contractHealth and Human S · Expert Stx Scalable Transfection System$107K
  • Federal contractHealth and Human S · Maxcyte E-atx Cell Processor$50K
  • Federal contractHealth and Human S · Atx & Gtx Exploration Systems Preventative Maintenance$30K
  • Private capital raisedForm D · SEC · 3rd filing$760K
  • Private capital raisedForm D · SEC · 2nd filing$1.7M
  • Private capital raisedForm D · SEC · 1st filing$1.1M
Show 18 earlier federal awards
  • Federal contractHealth and Human S · Transfection Processing Assemblies$18K
  • Federal contractVeterans Affairs · Tsx Ultra Low Temperature Freezer #TSX60086A 115V/60HZ And Rack #920090$34K
  • Federal contractHealth and Human S · Scalable Transfection System$62K
  • Federal contractHealth and Human S · Maxcyte Atx Electroporation System$40K
  • Federal contractHealth and Human S · Electroporation&scalable Transfection System$114K
  • Federal contractHealth and Human S · Maxcyte Processing Assemblies$24K
  • Federal contractHealth and Human S · Ambis # 1965250 Consumables$15K
  • Federal contractHealth and Human S · Maxcyte Atx Scalable Transfection System$55K
  • Federal contractHealth and Human S · Maxcyte Atx Scaleable Transfection System With Software Licenses, Quote # MM201907B, Cat # ATX100 Maxcyte$50K
  • Federal contractHealth and Human S · Processing Assembly, CL-1.1 3.5-ML (reagents)$12K
  • Federal contractHealth and Human S · Maxcyte, INC.:1141406 [19-003525]$60K
  • Federal contractHealth and Human S · Processing Assembly, CL-1.1 3.5-ML (reagents)$12K
  • Federal contractHealth and Human S · Transfection System$81K
  • Federal contractVeterans Affairs · Transfection Systems$165K
  • Federal contractHealth and Human S · Igf::it::igf$120K
  • Federal contractHealth and Human S · 1 Year Lease Of 1 Maxcyte Gt Flow Transfection System Including Licensing, Software, On Site Upgrade, Maintenance, Training Of NIH Staff, Service$375K
  • Federal contractHealth and Human S · Igf::ot::igf 1 Year Lease Of 1 Maxcyte? Gt? Flow Transfection System$100K
  • Federal contractHealth and Human S · POKDE080409ALUEDERS - Maxcyte - New Req# 508161 - Orig Req# 487642 - 12 Mos Service Contract$5K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

13months

from MAXCYTE, INC.’s first federal award to its first private round.

First federal award · Jul 2008
Health and Human S · $5K
First Form D · Aug 2009
$1.1M · 1st Form D
Awards before first raise
1 award

An association in public records, not a cause or a prediction.

Standing among 32 peers

Line = median

Biotech · Device

  • Granted patents#1 · top 3%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Arthur Starke MandellDirectorNamed in SEC Form D filings
  • Chris HegeleDirectorNamed in SEC Form D filings
  • David Starke PiersonDirectorNamed in SEC Form D filings
  • Dennis Stark DoughertyDirectorNamed in SEC Form D filings
  • Douglas A. DoerflerExecutive Officer, DirectorNamed in SEC Form D filings
  • John Stark JohnstonDirectorNamed in SEC Form D filings
Show all 18 people
  • J Stark ThompsonDirectorNamed in SEC Form D filings
  • J. Starke ThompsonDirectorNamed in SEC Form D filings
  • Karen Starke DonatoExecutive OfficerNamed in SEC Form D filings
  • Madhusadan E. PeshwaExecutive OfficerNamed in SEC Form D filings
  • Madhusudan V PeshwaExecutive OfficerNamed in SEC Form D filings
  • Ronald E. HoltzExecutive OfficerNamed in SEC Form D filings
  • Sinclair Starke DunlopDirectorNamed in SEC Form D filings
  • Stan Stark ErckDirectorNamed in SEC Form D filings
  • Stanley C ErckDirectorNamed in SEC Form D filings
  • Thomas M RossExecutive OfficerNamed in SEC Form D filings
  • Will Stark BrookeDirectorNamed in SEC Form D filings
  • William Stark BrookeDirectorNamed in SEC Form D filings

What it has protected

USPTO · 28 granted of 40
  • GrantedRackUSPTOUS D1,140,087
  • GrantedElectroporation DeviceUSPTOUS D1,122,471
  • PendingApparatus And Methods For ElectroporationUSPTOApplication 19109342
Show all 40 patent records

Related companies, and why

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .